Moreover, the expression level of SLC1A4 was strongly associated with tumor size and TNM stage, suggesting that SLC1A4 may have contributed to the progression of GC (P<0.05, Figure 8C and Table S1, Supporting Information). This evidence concerns the gene SLC1A4 and gastric cancer.